IOL CHEMICALS & PHARM. | KABRA DRUGS | IOL CHEMICALS & PHARM./ KABRA DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | -6.2 | - | View Chart |
P/BV | x | 1.6 | - | - | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. KABRA DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
KABRA DRUGS Mar-23 |
IOL CHEMICALS & PHARM./ KABRA DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 6 | 9,415.8% | |
Low | Rs | 272 | 3 | 9,227.1% | |
Sales per share (Unadj.) | Rs | 377.6 | 0 | - | |
Earnings per share (Unadj.) | Rs | 23.7 | -0.8 | -3,078.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -0.8 | -4,099.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | -1.7 | -15,422.5% | |
Shares outstanding (eoy) | m | 58.71 | 4.39 | 1,337.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0 | - | |
Avg P/E ratio | x | 17.1 | -5.6 | -303.9% | |
P/CF ratio (eoy) | x | 12.8 | -5.6 | -228.2% | |
Price / Book Value ratio | x | 1.6 | -2.6 | -60.7% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 19 | 125,097.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2 | 72,504.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 0 | - | |
Other income | Rs m | 256 | 0 | 426,833.3% | |
Total revenues | Rs m | 22,427 | 0 | 37,378,666.7% | |
Gross profit | Rs m | 2,257 | -3 | -65,601.7% | |
Depreciation | Rs m | 462 | 0 | - | |
Interest | Rs m | 165 | 0 | - | |
Profit before tax | Rs m | 1,887 | -3 | -55,813.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | - | |
Profit after tax | Rs m | 1,391 | -3 | -41,165.7% | |
Gross profit margin | % | 10.2 | 0 | - | |
Effective tax rate | % | 26.2 | 0 | - | |
Net profit margin | % | 6.3 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 7 | 142,154.4% | |
Current liabilities | Rs m | 5,025 | 14 | 35,018.8% | |
Net working cap to sales | % | 20.9 | 0 | - | |
Current ratio | x | 1.9 | 0.5 | 405.9% | |
Inventory Days | Days | 43 | 0 | - | |
Debtors Days | Days | 8 | 0 | - | |
Net fixed assets | Rs m | 11,017 | 0 | 4,790,173.9% | |
Share capital | Rs m | 587 | 44 | 1,337.7% | |
"Free" reserves | Rs m | 14,490 | -51 | -28,301.0% | |
Net worth | Rs m | 15,077 | -7 | -206,254.4% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 7 | 293,805.4% | |
Interest coverage | x | 12.5 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0 | - | |
Return on assets | % | 7.5 | -48.0 | -15.7% | |
Return on equity | % | 9.2 | 46.2 | 20.0% | |
Return on capital | % | 13.6 | 46.2 | 29.5% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -4 | -34,539.5% | |
From Investments | Rs m | -1,200 | NA | - | |
From Financial Activity | Rs m | -41 | 4 | -1,154.5% | |
Net Cashflow | Rs m | -18 | 0 | -92,000.0% |
Indian Promoters | % | 48.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 100.0 | 51.8% | |
Shareholders | 130,003 | 7,364 | 1,765.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | KABRA DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | 0.00% | 0.45% |
1-Month | 5.76% | 0.00% | 2.55% |
1-Year | -2.63% | 33.15% | 56.14% |
3-Year CAGR | -12.88% | 20.59% | 15.22% |
5-Year CAGR | 16.82% | 64.33% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the KABRA DRUGS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of KABRA DRUGS the stake stands at 0.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of KABRA DRUGS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
KABRA DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of KABRA DRUGS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.